Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucio Cocco

Showing results (181-190 of 238) with videos related to

Pageof 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDSMatilde Y Follo, Carlo Finelli, Sara Mongiorgi, et al.
Advances in Biological Regulation|November 4, 2015
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cellsWilliam H Chappell, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Cellular and Molecular Life Sciences : CMLS|March 18, 2022
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressivenessStefano Ratti, Maria Vittoria Marvi, Sara Mongiorgi, et al.
Advances in Biological Regulation|October 18, 2012
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatmentWilliam H Chappell, Stephen L Abrams, Kristin M Stadelman, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Cells|March 18, 2020
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic SyndromesJie Xian, Eric Owusu Obeng, Stefano Ratti, et al.
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)Alessandro Poli, Stefano Ratti, Carlo Finelli, et al.
Pageof 24

Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDSMatilde Y Follo, Carlo Finelli, Sara Mongiorgi, et al.
Advances in Biological Regulation|November 4, 2015
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cellsWilliam H Chappell, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Cellular and Molecular Life Sciences : CMLS|March 18, 2022
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressivenessStefano Ratti, Maria Vittoria Marvi, Sara Mongiorgi, et al.
Advances in Biological Regulation|October 18, 2012
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatmentWilliam H Chappell, Stephen L Abrams, Kristin M Stadelman, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Cells|March 18, 2020
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic SyndromesJie Xian, Eric Owusu Obeng, Stefano Ratti, et al.
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)Alessandro Poli, Stefano Ratti, Carlo Finelli, et al.
Pageof 24